Diebold Nixdorf, Incorporated
DBDNYSETechnology● Active
$82.74
+$1.60(+1.97%)
Market Cap$2.9B
P/E Ratio—
52W High$89.05
52W Low$49.15
Diebold Nixdorf, Incorporated (DBD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DBD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$0.60
Est. $0.61 · -1.6%
Revenue
$0.89B
Est. $0.85B · +5.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
DBD reports quarterly as a NYSE-listed Software - Application company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $1.10 | — | — | — | $0.92B | — |
| ▼ Q2 FY2026 | Apr 30, 2026 | $0.61 | $0.60 | -1.6% | $0.89B | $0.85B | +5.0% |
| ▲ Q1 FY2026 | Feb 12, 2026 | $1.61 | $3.02 | +87.6% | $1.10B | $1.11B | -0.8% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.66 | $1.39 | +110.6% | $0.95B | $1.11B | -15.2% |
| ▼ Q3 FY2025 | Aug 6, 2025 | $0.61 | $0.60 | -1.6% | $0.92B | $0.99B | -7.3% |
| ▼ Q2 FY2025 | May 7, 2025 | $0.55 | $0.07 | -87.3% | $0.84B | $0.88B | -4.5% |
| ▼ Q1 FY2025 | Feb 12, 2025 | $1.05 | $0.97 | -7.6% | $0.99B | $0.99B | +0.1% |
| ▼ Q4 FY2024 | Nov 7, 2024 | $1.36 | $0.53 | -61.0% | $0.93B | $0.99B | -6.1% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$1.10
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Miss
EPS Actual
$0.60
EPS Est.
$0.61
EPS Surpr.
-1.6%
Revenue
$0.89B
Q1 FY2026
Feb 12, 2026Beat
EPS Actual
$3.02
EPS Est.
$1.61
EPS Surpr.
+87.6%
Revenue
$1.10B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$1.39
EPS Est.
$0.66
EPS Surpr.
+110.6%
Revenue
$0.95B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
$0.60
EPS Est.
$0.61
EPS Surpr.
-1.6%
Revenue
$0.92B
Q2 FY2025
May 7, 2025Miss
EPS Actual
$0.07
EPS Est.
$0.55
EPS Surpr.
-87.3%
Revenue
$0.84B
Q1 FY2025
Feb 12, 2025Miss
EPS Actual
$0.97
EPS Est.
$1.05
EPS Surpr.
-7.6%
Revenue
$0.99B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
$0.53
EPS Est.
$1.36
EPS Surpr.
-61.0%
Revenue
$0.93B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $2.53 | $2.54 | $2.56 | 1 |
| Q3 FY2027 | $1.73 | $1.74 | $1.75 | 1 |
| Q2 FY2027 | $1.52 | $1.52 | $1.53 | 1 |
| Q1 FY2027 | $1.12 | $1.13 | $1.13 | 1 |
| Q4 FY2026 | $2.25 | $2.27 | $2.28 | 1 |
| Q3 FY2026 | $1.44 | $1.45 | $1.46 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $1.1B | $1.1B | $1.1B | 1 |
| Q3 FY2027 | $1.0B | $1.0B | $1.0B | 1 |
| Q2 FY2027 | $1.0B | $1.0B | $1.0B | 1 |
| Q1 FY2027 | $0.9B | $0.9B | $0.9B | 1 |
| Q4 FY2026 | $1.1B | $1.1B | $1.1B | 1 |
| Q3 FY2026 | $1.0B | $1.0B | $1.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 30, 2026 | -1.6% | $82.96 | $76.81 | -7.41% |
| ▲ Q1 FY2026 | Feb 12, 2026 | +87.6% | $72.36 | $75.59 | +4.46% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +110.6% | $56.24 | $63.24 | +12.45% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -1.6% | $56.22 | $59.47 | +5.78% |
| ▼ Q2 FY2025 | May 7, 2025 | -87.3% | $45.25 | $44.00 | -2.76% |
| ▼ Q1 FY2025 | Feb 12, 2025 | -7.6% | $44.00 | $46.36 | +5.36% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -61.0% | $49.89 | $43.04 | -13.73% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +4.5% | $37.03 | $40.90 | +10.45% |
Q2 FY2026-7.41%
Report Date
Apr 30, 2026
EPS Beat/Miss
-1.6%
Price Before
$82.96
Price After
$76.81
Q1 FY2026+4.46%
Report Date
Feb 12, 2026
EPS Beat/Miss
+87.6%
Price Before
$72.36
Price After
$75.59
Q4 FY2025+12.45%
Report Date
Nov 5, 2025
EPS Beat/Miss
+110.6%
Price Before
$56.24
Price After
$63.24
Q3 FY2025+5.78%
Report Date
Aug 6, 2025
EPS Beat/Miss
-1.6%
Price Before
$56.22
Price After
$59.47
Q2 FY2025-2.76%
Report Date
May 7, 2025
EPS Beat/Miss
-87.3%
Price Before
$45.25
Price After
$44.00
Q1 FY2025+5.36%
Report Date
Feb 12, 2025
EPS Beat/Miss
-7.6%
Price Before
$44.00
Price After
$46.36
Q4 FY2024-13.73%
Report Date
Nov 7, 2024
EPS Beat/Miss
-61.0%
Price Before
$49.89
Price After
$43.04
Q3 FY2024+10.45%
Report Date
Aug 7, 2024
EPS Beat/Miss
+4.5%
Price Before
$37.03
Price After
$40.90
Avg Beat Reaction+9.12%
Avg Miss Reaction-2.55%
Beat Rate3 / 8 quarters
Largest Move-13.73% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DBD ends December
Diebold Nixdorf, Incorporated (DBD) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $0.60 — missing the analyst consensus of $0.61 by -1.6%. The next DBD earnings date is expected around September 1, 2026.
Each quarter, investors track DBD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DBD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DBD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DBD earnings · 5 questionsDiebold Nixdorf, Incorporated's next earnings report is expected around September 1, 2026. DBD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DBD historically reports after market close (AMC).
DBD earnings datewhen is DBD earningsDBD next earnings datewhen does DBD report earningsDBD earnings calendar
▸ Source: FMP · Diebold Nixdorf, Incorporated SEC filings · US GAAP · Diebold Nixdorf, Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026